Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | TYK2 | P29597 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610450 | 0.95 | GRM5 (0.33) | MAPK14ALOX5PRKDCPIK3R2GRM5 | |
| SCHEMBL17035676 | 0.95 | MAPK14 (0.33) | MAPK14ALOX5PRKDCPIK3R2BRD4 | |
| SCHEMBL5028299 | 0.94 | MAPK14 (0.32) | MAPK14ALOX5PRKDCPIK3R2GRM5 | |
| SCHEMBL16919802 | 0.94 | MAPK14 (0.32) | MAPK14ALOX5PRKDCPIK3R2NPY5R | |
| SCHEMBL12925710 | 0.91 | GRM5 (0.34) | MAPK14PRKDCGRM5 | |
| SCHEMBL5028237 | 0.89 | ALOX5 (0.32) | MAPK14ALOX5PRKDCPIK3R2 | |
| SCHEMBL12925729 | 0.88 | ALOX5 (0.31) | MAPK14ALOX5PRKDCNPY5R | |
| SCHEMBL12925664 | 0.87 | GRM5 (0.31) | GRM5 | |
| SCHEMBL5028305 | 0.87 | GRM5 (0.31) | GRM5 | |
| SCHEMBL12925570 | 0.86 | MAPK14 (0.34) | MAPK14ALOX5PRKDCJAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2930762-B1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, AND DISPLAY DEVICE | KONICA MINOLTA INC (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-10468610-B2 | Isomer-mixture metal complex composition, organic electroluminescent element, illuminator, and display device | Konica Minolta, Inc. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-10347850-B2 | Organic electroluminescent element, lighting device and display device | Konica Minolta, Inc. (JP) | 2019-07-09 | — | — | US | disclosed |
| US-10177322-B2 | Iridium complex, method for producing iridium complex, organic electroluminescent element, display device, and lighting device | Konica Minolta, Inc. (JP) | 2019-01-08 | — | — | US | disclosed |
| US-9960356-B2 | Organic electroluminescence device, lighting equipment and display device | Konica Minolta, Inc. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960356-B2 | Organic electroluminescence device, lighting equipment and display device | Konica Minolta, Inc. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9944629-B2 | Material for organic electroluminescent element, organic electroluminescent element, illumination device, and display device | Konica Minolta, Inc. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9944629-B2 | Material for organic electroluminescent element, organic electroluminescent element, illumination device, and display device | Konica Minolta, Inc. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-20170309839-A1 | IRIDIUM COMPLEX, METHOD FOR PRODUCING IRIDIUM COMPLEX, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | KONICA MINOLTA INC (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170309839-A1 | IRIDIUM COMPLEX, METHOD FOR PRODUCING IRIDIUM COMPLEX, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | KONICA MINOLTA INC (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20150179958-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150179958-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-2884552-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-9040975-B2 | Organic electroluminescence element, illumination device, and display device | Konica Minolta, Inc. (JP) | 2015-05-26 | — | — | US | disclosed |
| US-9040975-B2 | Organic electroluminescence element, illumination device, and display device | Konica Minolta, Inc. (JP) | 2015-05-26 | — | — | US | disclosed |
| US-20130099216-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20130099216-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-04-25 | — | — | US | disclosed |
| EP-2584019-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE | Konica Minolta Holdings, Inc. (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-20120018714-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY APPARATUS, AND LIGHTING APPARATUS | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120018714-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY APPARATUS, AND LIGHTING APPARATUS | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10468610-B2 | Isomer-mixture metal complex composition, organic electroluminescent element, illuminator, and display device | EMC2, ELP1, EMC1 | MAPK14 2582/4885ALOX5 975/4885PRKDC 4191/4885 |
| US-10177322-B2 | Iridium complex, method for producing iridium complex, organic electroluminescent element, display device, and lighting device | EED, SNW1, AP2M1 | MAPK14 4606/4885ALOX5 1708/4885PRKDC 2772/4885 |
| US-20170309839-A1 | IRIDIUM COMPLEX, METHOD FOR PRODUCING IRIDIUM COMPLEX, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | EED, SNW1, AP2M1 | MAPK14 4606/4885ALOX5 1708/4885PRKDC 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.